Krystal Biotech (KRYS) EPS (Basic) Growth (3y) (2019 - 2026)
Krystal Biotech (KRYS) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
85.94% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
41.58% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Krystal Biotech |
10.23 Bn |
9.41 Bn |
110.03 Mn |
45.58% |
| Date | Value |
|---|
| Mar 31, 2026 |
45.58% |
| Dec 31, 2025 |
50.60% |
| Sep 30, 2025 |
63.14% |
| Jun 30, 2025 |
47.50% |
| Mar 31, 2025 |
37.91% |
| Dec 31, 2024 |
54.30% |
| Sep 30, 2024 |
49.73% |
| Jun 30, 2024 |
39.76% |
| Mar 31, 2024 |
26.84% |
| Dec 31, 2023 |
37.57% |
| Sep 30, 2023 |
98.97% |
| Jun 30, 2023 |
-50.05% |
| Mar 31, 2023 |
-78.40% |
| Dec 31, 2022 |
-59.17% |
| Sep 30, 2022 |
-67.27% |
| Jun 30, 2022 |
-43.79% |
| Mar 31, 2022 |
-90.03% |
| Dec 31, 2021 |
-50.26% |
| Sep 30, 2021 |
-39.12% |
| Jun 30, 2021 |
-49.83% |
